Literature DB >> 26316244

Menopausal Hormone Therapy: Current Considerations.

Cynthia A Stuenkel1.   

Abstract

Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor and vaginal symptoms. Today, symptomatic women younger than 60 years of age or less than 10 years since onset of menopause yield the greatest benefit of MHT with the lowest risks when compared with older women remote from menopause. Careful assessment before initiating therapy includes severity of bothersome symptoms, treatment preferences, medical history, presence of contraindications to MHT, and personal risk of cardiovascular disease and breast cancer. Considerations of type of MHT, dosing, and route of administration, and recommendations regarding duration of therapy are discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bazedoxifene; Estrogen; Menopausal hormone therapy; Ospemifene; Progestogen; Selective estrogen receptor modulator

Mesh:

Year:  2015        PMID: 26316244     DOI: 10.1016/j.ecl.2015.05.006

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Menopause and postmenopausal hormone therapy and risk of hearing loss.

Authors:  Sharon G Curhan; A Heather Eliassen; Roland D Eavey; Molin Wang; Brian M Lin; Gary C Curhan
Journal:  Menopause       Date:  2017-09       Impact factor: 2.953

2.  Hemochromatosis and Xeroderma Pigmentosum: Two (Un)Suspicious Neighbors.

Authors:  Filipa Monte; Mónica Garrido; Tiago Pereira Guedes; Joel Reis; Graça Porto; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2021-02-05

3.  Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model.

Authors:  Paul Jonathan Roch; Danny Henkies; Jan Christoph Carstens; Carsten Krischek; Wolfgang Lehmann; Marina Komrakova; Stephan Sehmisch
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-17       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.